ZEPP HEALTH CORP-ADR
ZEPPNYSETrading Snapshot
- Day Range
- $3.93 – $3.99
- 52-Week Range
- $3.81 – $61.85
- Volume
- $4.18B
- Avg Volume
- $3.58B
- Shares Outstanding
- 14.3M
- Next Earnings
- Nov 20, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.82B
- Last Q Revenue
- $434M
- P/E Ratio
- -0.1
- P/S Ratio
- 0.2x
- EPS (TTM)
- $-304.63
- Dividend Yield
- 0.00%
- Dilution (1yr)
- −93.9%
Why Investors Own ZEPP
- ✓High-growth profile — revenue up +6.9% YoY with expanding US Equity exposure.
- ✓Healthy economics — 77% gross margin and 14% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ZEPP HEALTH CORP-ADR
ZEPP
StockOtter · stockotter.spaceAbout ZEPP HEALTH CORP-ADR
Headquartered in Hefei, China, and established in 2013, Zepp Health Corporation (known as Huami Corporation until its rebranding in February 2021) is a technology firm specializing in the creation, production, and sale of intelligent wearable devices. Operating predominantly within the People's Republic of China, the company divides its operations into two main segments: Xiaomi Wearable Products and its own-branded products and other ventures. Its diverse product range includes smart bands, watches, and scales, in addition to hearable devices, home fitness equipment like treadmills, sportswear, selected home appliances, and various smartwatch accessories. These offerings are marketed under both the Xiaomi and Amazfit brands. Zepp Health also empowers users with detailed analyses of their collected activity and biometric data, presented through intuitive charts and graphs accessible via its proprietary Zepp Life and Zepp mobile applications.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
Zepp Health Corporation (ZEPP) Q2 2026 Earnings Call Transcript
Zepp Health Corporation (ZEPP) Q2 2026 Earnings Call Transcript
Zepp Health Q2 Earnings Call Highlights
Zepp Health NYSE: ZEPP reported second-quarter 2026 revenue of $63.5 million, up 6.9% from a year earlier, as new product launches and a higher-priced product mix supported growth. Gross margin improved to 37.4% from 36.
Zepp Health Corporation Reports Second Quarter of 2026 Unaudited Financial Results
Zepp Health Corporation Reports Second Quarter of 2026 Unaudited Financial Results PR Newswire MILPITAS, Calif., S
Zepp Health Corporation to Report Second Quarter 2026 Financial Results on September 1, 2026
Earnings Call Scheduled for 9:30 p.m. ET on September 1, 2026 MILPITAS, Calif.